Acute Lymphocytic Leukemia (ALL) Active Not Recruiting Phase 2 Trials for DB01008 (Busulfan)

Also known as: Acute Lymphocytic Leukemia / Acute Lymphoid Leukemia (ALL) / Acute Lymphatic Leukemia / Acute Lymphocytic Leukaemia / Acute Lymphoid Leukemia / Acute lymphoblastic leukemia with failed remission / Acute lymphoblastic leukaemia / Leukemia lymphoblastic acute / Acute lymphoblastic leukemia / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / ALL / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic

IndicationStatusPhase
DBCOND0030518 (Acute Lymphocytic Leukemia (ALL))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01338987Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow TransplantationTreatment
NCT01572662Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine ConditioningTreatment